A Short Contemporary History of Disseminated Intravascular Coagulation

被引:52
作者
Levi, Marcel [1 ]
van der Poll, Tom [1 ,2 ,3 ]
机构
[1] Univ Amsterdam, Dept Med, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands
关键词
disseminated intravascular coagulation; history; microvascular thrombosis; tissue factor; coagulation inhibitors; fibrinolysis; inflammation; ACTIVATED PROTEIN-C; TUMOR-NECROSIS-FACTOR; ACUTE PROMYELOCYTIC LEUKEMIA; FACTOR PATHWAY INHIBITOR; COLI SEPTIC SHOCK; PLASMINOGEN-ACTIVATOR; ESCHERICHIA-COLI; INTERNATIONAL SOCIETY; CONTACT SYSTEM; TISSUE FACTOR;
D O I
10.1055/s-0034-1395155
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Disseminated intravascular coagulation (DIC) is a syndrome characterized by systemic intravascular activation of coagulation, leading to a widespread deposition of fibrin in the circulation. There is ample experimental and pathological evidence that the fibrin deposition contributes to multiple organ failure. The massive and ongoing activation of coagulation may result in depletion of platelets and coagulation factors, which may cause bleeding (consumption coagulopathy). The syndrome of DIC is well known in the medical literature for centuries, although a more precise description of the underlying mechanisms had to await the 20th century. Initial ideas on a role of the contact activation system as the primary trigger for the systemic activation of coagulation as well as a presumed hyperfibrinolytic response in DIC have been found to be misconceptions. Experimental and clinical evidence now indicate that the initiation of coagulation in DIC is caused by tissue factor expression, which in combination with downregulated physiological anticoagulant pathways and impaired fibrinolysis leads to widespread fibrin deposition. In addition, an extensive bidirectional interaction between coagulation and inflammation may further contribute to the pathogenesis of DIC.
引用
收藏
页码:874 / 880
页数:7
相关论文
共 98 条
[1]  
ALBARRACIN NS, 1971, AM J CLIN PATHOL, V55, P677
[2]   PATHOGENESIS OF COAGULATION DEFECT DEVELOPING DURING PATHOLOGICAL PLASMA PROTEOLYTIC (FIBRINOLYTIC) STATES .2. SIGNIFICANCE, MECHANISM AND CONSEQUENCES OF DEFECTIVE FIBRIN POLYMERIZATION [J].
ALKJAERSIG, N ;
SHERRY, S ;
FLETCHER, AP .
JOURNAL OF CLINICAL INVESTIGATION, 1962, 41 (04) :917-&
[3]  
[Anonymous], 1965, JAMA-J AM MED ASSOC
[4]   An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation [J].
Asakura, H ;
Ontachi, Y ;
Mizutani, T ;
Kato, M ;
Saito, M ;
Kumabashiri, I ;
Morishita, E ;
Yamazaki, M ;
Aoshima, K ;
Nakao, S .
CRITICAL CARE MEDICINE, 2001, 29 (06) :1164-1168
[5]  
AVVISATI G, 1989, LANCET, V2, P122
[6]   ACQUIRED ALPHA-2-ANTIPLASMIN DEFICIENCY IN ACUTE PROMYELOCYTIC LEUKEMIA [J].
AVVISATI, G ;
TENCATE, JW ;
STURK, A ;
LAMPING, R ;
PETTI, MC ;
MANDELLI, F .
BRITISH JOURNAL OF HAEMATOLOGY, 1988, 70 (01) :43-48
[7]   Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation [J].
Bakhtiari, K ;
Meijers, JCM ;
de Jonge, E ;
Levi, M .
CRITICAL CARE MEDICINE, 2004, 32 (12) :2416-2421
[8]  
BIEMOND BJ, 1995, THROMB HAEMOSTASIS, V73, P223
[9]   PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 RELEASE DURING EXPERIMENTAL ENDOTOXEMIA IN CHIMPANZEES - EFFECT OF INTERVENTIONS IN THE CYTOKINE AND COAGULATION CASCADES [J].
BIEMOND, BJ ;
LEVI, M ;
TENCATE, H ;
VANDERPOLL, T ;
BULLER, HR ;
HACK, CE ;
TENCATE, JW .
CLINICAL SCIENCE, 1995, 88 (05) :587-594
[10]   PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND INHIBITOR-2, ALPHA-2-ANTIPLASMIN, PLASMINOGEN, AND ENDOTOXIN LEVELS IN SYSTEMIC MENINGOCOCCAL DISEASE [J].
BRANDTZAEG, P ;
JOO, GB ;
BRUSLETTO, B ;
KIERULF, P .
THROMBOSIS RESEARCH, 1990, 57 (02) :271-278